Andrew Peterson, MD
Urology · Durham, NCNPI 1104871367
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $80,000 of the $123,988 with a category attached, or 64.5%. Boston Scientific accounts for 99.1% of it on its own, with 4 other manufacturers making up the rest. Reporting peaked in 2020 at $29,608 and has fallen 94.3% since, to $1,701 in 2025. Among urology clinicians in NC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 84 payments — averaging $1476.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$123K
- Uromedica, Incorporated$927
- Abbott$140
- Photocure Inc$19
- Johnson & Johnson$15
Across 50 payments — averaging $3450.68 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Boston Scientific$157K
- Urovant Sciences Inc$15K
What the payments were for
- Consulting fees$17,76314%
- Speaking & faculty fees$80,00065%
- Travel & lodging$23,88119%
- Food & beverage$2,3442%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 80 | $122,887 |
| Uromedica, Incorporated | 1 | $927 |
| Abbott | 1 | $140 |
| Photocure Inc | 1 | $19 |
| Johnson & Johnson | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GENERAL ERECTILE DYSFUNCTION$28,095
- GENERAL - THERAPIES$22,665
- ADVANCE$20,862
- TACTRA$15,400
- AMS$7,741
- AMS 700$1,771
- ProACT$927
- AMS 800 Artificial Urinary Sphincter$698
- AMS 700 CXR RTE KIT$450
- AMPLATZER$140
- LithoVue$116
How this compares
$123,988 in reported general payments places this provider in the 95th percentile of 434 urology providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 15 | $15,471 |
| Solifenacin Succinate | 14 | $989 |
| Trimethoprim | 11 | $622 |
| Tamsulosin Hcl | 26 | $254 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 12 | $236 |
| Finasteride | 16 | $216 |
Paid to pharmacies, not to this prescriber.
Other urology in Durham
- Judd MoulDurham$1M
- Daniel GeorgeDurham$1M
- Glenn PremingerDurham$736K
- Michael LipkinDurham$293K
- Jay KimDurham$202K
- Cary RobertsonDurham$76K
- Brant InmanDurham$55K
- Thomas PolascikDurham$54K
- Robert MedairosDurham$27K
- Edward HouserDurham$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.